Skip to main content
HR 5926 115th Congress House Health Drug therapy Drug, alcohol, tobacco use Health promotion and preventive care Health technology, devices, supplies Prescription drugs

Naloxone Guidelines Act of 2018

Introduced: May 23, 2018 Introduced by: Keating, William R. Democratic · Massachusetts See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 23, 2018
Referred to the House Committee on Energy and Commerce.
May 23, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Naloxone Guidelines Act of 2018

This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).

The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:

  • co-prescription with an opioid;
  • safe dosages;
  • prescription for non-patients; and
  • standing orders (i.e., orders that allow dispensing without a prescription).
What's happening now May 23, 2018

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1